Currency in USD
Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | -0.17 | -0.05 | -0.32 | -0.11 |
Low estimate | -0.21 | -0.08 | -0.4 | -0.13 |
High estimate | -0.13 | -0.02 | -0.24 | -0.09 |
Year ago EPS | -18 | -8.93 | -29.44 | -0.32 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | 10M | 14.09M | 51.5M | 55.5M |
Low estimate | 9.7M | 13.79M | 51M | 53.6M |
High estimate | 10.49M | 14.3M | 52M | 57.21M |
Year ago sales | 10.47M | 14.29M | 49.16M | 51.5M |
Sales growth (year/est) | -4.50% | -1.40% | 4.80% | 7.80% |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|
Est. EPS | -19.67 | -5.33 | -1.85 | -2.55 |
Actual EPS | -18 | -8.93 | -3.89 | -1.76 |
Difference | 1.67 | -3.6 | -2.04 | 0.79 |
Surprise % | 8.50% | -67.50% | -110.30% | 31.00% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | -0.17 | -0.05 | -0.32 | -0.11 |
7 days ago | -0.17 | -0.05 | -0.32 | -0.11 |
30 days ago | -0.17 | -0.05 | -0.32 | -0.11 |
60 days ago | -0.89 | -0.47 | -1.84 | -0.1 |
90 days ago | -1.8 | -1.23 | -4.88 | -1.52 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | BIOL | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | 99.10% | N/A | N/A | N/A |
Next qtr. | 99.40% | N/A | N/A | N/A |
Current year | 98.90% | N/A | N/A | N/A |
Next year | 65.60% | N/A | N/A | N/A |
Next 5 years (per annum) | 20.00% | N/A | N/A | N/A |
Past 5 years (per annum) | 13.59% | N/A | N/A | N/A |